Martin Glen

Martin Glen has a diverse work experience that spans across various industries and roles. Martin worked as a Partner at Cheyne Capital from April 2014 to December 2015. Prior to that, they were an Analyst/Portfolio Manager at Meditor for nine years, where they specialized in analyzing IPOs and follow-on offerings across all sectors and geographies. Martin also held positions at Jefferies Europe and Lazard Capital Markets as an Analyst/Sales and Senior Analyst, respectively. Martin was responsible for covering small and midcap European pharmaceutical companies and extensively marketed companies and ideas to fund managers globally. Before that, Martin worked as an Analyst at Lehman Brothers Asia, where they covered industries such as oil & gas, petrochemical, synthetic fiber, and other cyclical industries. Currently, they hold Non Executive Director roles at Charco Neurotech, Wayland Additive, and Director roles at Parkwalk Advisors and Psyomics Ltd.

Martin Glen attended Tonbridge School from 1977 to 1983. Martin then pursued a Bachelor of Arts (Honors) degree in Chemistry at St. Edmund Hall, Oxford University, from 1983 to 1987.